← Cas cliniques · ERCP

Navigating the Hilar Dilemma: When Cholangioscopy Rewrites the Staging

MRCP said Klatskin IIIa. The mucosa said otherwise.

1 septembre 2026Vidéo 6:51Lecture 1 minDr Sami Boudabbous

Radiology can sometimes paint a definitive, alarming picture. A 61-year-old patient presented with intense jaundice, and the MRCP strongly suggested a Bismuth-Corlette type IIIa Klatskin tumor — a 15 mm common hepatic duct stricture with dilated left and right hepatic ducts and parenchymal edema.

Direct digital cholangioscopy revealed a completely normal, clean mucosa with no signs of infiltration.

The clinical challenge

Cross-sectional imaging and cholangiograms frequently struggle to differentiate malignant hilar cholangiocarcinoma from benign inflammatory strictures. Treating the imaging rather than the true mucosal anatomy risks unnecessary radical interventions.

The procedural approach

  • Spy-assisted mapping. The CBD and left hepatic duct were cannulated easily, but no contrast crossed into the blocked right hepatic duct. Injecting contrast through the SpyGlass channel illuminated its path.
  • Overcoming wire looping. Using the 4-way deflection of the cholangioscope to face the exact entrance of the right hepatic duct, the wire crossed smoothly.
  • Tactile compliance. Malignant strictures are typically rigid. Smoothly negotiating the tight stricture pointed away from a fixed, malignant wall.
  • Direct visualization. Pristine, non-infiltrated mucosal architecture.
  • Graduated decompression. Rather than forcing immediate metal stent deployment, two 10 Fr × 15 cm plastic stents for sequential, controlled dilation.

The outcome

Pruritus resolved within 48 hours, with rapid clearance of jaundice and an uneventful recovery. Direct visualization, favorable tactile feedback and negative biopsies corrected the diagnostic trajectory.

Access the proximal ducts properly and a complex hilar bottleneck becomes a manageable mechanical problem.

Contenu destiné aux médecins et professionnels de santé. Données anonymisées ; ce cas ne constitue pas une recommandation de prise en charge individuelle.

Adresser un patient